This work sought to define how pancreatitis affected antibiotic distribution in a perfused rat pancreas model. The distribution kinetics of four antibiotics were examined in control animals and animals with pancreatitis. Meropenem and piperacillin distributed into the extracellular space, and their distribution kinetics were unaffected by pancreatitis. In contrast, in pancreatic cells from animals with pancreatitis, ciprofloxacin showed a reduced uptake and clindamycin showed a reduced distribution.
This work sought to define how pancreatitis affected antibiotic distribution in a perfused rat pancreas model. The distribution kinetics of four antibiotics were examined in control animals and animals with pancreatitis. Meropenem and piperacillin distributed into the extracellular space, and their distribution kinetics were unaffected by pancreatitis. In contrast, in pancreatic cells from animals with pancreatitis, ciprofloxacin showed a reduced uptake and clindamycin showed a reduced distribution.
Although the use of antibiotics in treating pancreatitis still remains controversial (3, 4, 15) , bacterial infection is the leading cause of morbidity and mortality in patients with severe acute pancreatitis (SAP) (14) . Studies have investigated penetration into diseased human tissue (1, 2, 5, 13), as well as a variety of animal models (6, 9, 10, 16) .
However, there appear to be few studies examining the rate of antibiotic uptake into pancreatic tissue. To our knowledge, this is one of the few studies investigating the rate of uptake of antibiotics in normal and diseased pancreas and most likely the first in the isolated perfused pancreas. Such a model enables the precise rate of uptake and efflux for antibiotics in the pancreas to be defined, as well as the nature of their distribution in the normal and diseased pancreas.
All procedures involving animals were carried out with adherence to the University of Queensland Animal Care Committee guidelines (Animal Ethics Committee [AEC] project PAH/588/06/NHMRC). Pancreatitis was induced by giving male Wistar rats a single injection of 6 mg of dibutyltin dichloride (DBTC) per kg of body weight, via the tail vein, according to a previously described method (16) . Rats were not allowed to eat from 104 h postinjection, and following the final blood sample at 120 h postinjection, they were anesthetized as previously described (8) . The pancreas perfusions were carried out similarly to the method described previously (8) with a series of 5 individual 20-l bolus injections (7): piperacillin (2 mg/ml), meropenem (1 mg/ml), ciprofloxacin (200 g/ml), clindamycin (1 mg/ml), and [
14 C]sucrose with 3 H-labeled water (each drug bolus contained 125 I-labeled albumin). The perfusate and outflow profiles were analyzed as described previously to obtain the unbound fraction in perfusate (fu), volume of distribution of albumin or albumin space (V alb ), volume of distribution of sucrose or sucrose space (V suc ), volume of distribution of water or water space (V water ), drug distribution volume (V), fraction unbound in tissues (fu T ), permeation rate constant k in (permeability rate constant from the vascular space to the extravascular space), efflux rate constant k out (permeability rate constant from the extravascular space to the vascular space), and permeability surface area product (PS) (7, 8) . Fibrosis was quantified using a method that has been previously utilized for the liver (11) .
Histological examination of the diseased pancreas showed pathologies, including the formation of ductal complexes with apoptotic and necrotic cells, massive inflammatory cell infiltration, fat necrosis, and leukocyte infiltration. The DBTCtreated animals had significantly increased fibrosis indexes (17.6% Ϯ 1.7% for animals with pancreatitis and 0.5% Ϯ 0.2% for control animals; P Ͻ 0.002), characterized by extensive collagen deposition. The dry/wet ratio of the pancreas preparation was unchanged in the diseased animals.
Similar albumin and sucrose spaces were seen for the control and pancreatitis models, but there was a significantly lower water space in animals with pancreatitis (P Ͻ 0.02) ( Table 1) . Thus, there was no difference in interstitial volume (0.15 Ϯ 0.02 ml ⅐ g Ϫ1 for control animals and 0.16 Ϯ 0.03 ml ⅐ g Ϫ1 for animals with pancreatitis), but there was a significantly lower cellular volume in the diseased pancreas (0.42 Ϯ 0.02 ml ⅐ g Ϫ1 for control animals and 0.29 Ϯ 0.03 ml ⅐ g Ϫ1 for animals with pancreatitis; P Ͻ 0.02). Figure 1 shows the outflow concentration-time profiles for the antibiotics in the perfused rat pancreas. Also included in Fig. 1 are the nonlinear regression fits of the physiologically based pharmacokinetic model used. The kinetic parameter estimates derived from these profiles are shown in Table 2 . It is evident that piperacillin and meropenem are mainly distributed into the sucrose space (i.e., perfusate plus interstitial). In addition, their disposition kinetics appear to be unaffected by the presence of pancreatitis. It is evident that the uptake of ciprofloxacin (as defined by PS, k in , and k in /k out ) into the pancreas is inhibited by pancreatitis but that its efflux is relatively unaffected. In contrast, the influx and efflux constants for clindamycin are unaffected by pancreatitis. In addition, the binding of clindamycin in pancreas tissue (fu T ) was unchanged (0.19 Ϯ 0.03 for control animals and 0.26 Ϯ 0.04 for animals with pancreatitis). Hence, as the extracellular (sucrose) space is unchanged, the decrease in V for clindamycin arises mainly from a decrease in the cellular space it distributes into in the pancreas (V ϭ V alb ϩ fu ⅐ V cellular /fu T ) (8) . This finding is consistent with the change in cellular volume based on the difference in the water and sucrose spaces as described above.
This work suggests that antibiotics with a distribution limited to the pancreas interstitial space are not significantly affected by pancreatitis, consistent with the similar extracellular spaces estimated using sucrose ( Table 1) . The result for piperacillin agrees with the finding of no change in penetration into diseased tissue as reported previously (19) . However, the current result for meropenem is in conflict with the work of Saglamkaya et al. (17) . They investigated animals both 6 h (disease characterized by edema) and 48 h (more necrotic tissue) following treatment with combined glycodexoxycholic acid infusion and intravenous cereulein to induce SAP. Meropenem's penetration was highest at 6 h (C pancreas /C serum ϭ 0.93, where C pancreas is the concentration of drug in pancreas and C serum is the concentration of drug in serum) and fell slightly, yet it was still significantly higher than the control at 48 h (C pancreas / C serum ϭ 0.81 versus C pancreas /C serum ϭ 0.33 for the control). Perhaps this penetration would continue to decrease with time as the diseased tissue becomes less edematous. Several studies have shown that penetration differences (both increased and decreased) into diseased versus control tissue are more marked in the earlier and/or more edematous forms of acute pancreatitis (9, 10, 17) , with evidence suggesting that this is related to capillary pancreatic blood flow (9) . The presence of more severe necrosis in Saglamkaya's work than in the present model may also have contributed to the higher penetration ratio at the 48-h time point. The significantly decreased uptake for ciprofloxacin in pancreatitis may reflect a potential active uptake of this compound into the pancreas and an inhibition of the uptake in pancreatitis due to fibrosis. There are a number of studies demonstrating active uptake of ciprofloxacin across epithelial cells (see, for example, reference 21); however, there do not appear to be any studies previously suggesting active uptake for ciprofloxacin in the pancreas. The almost 10-fold-higher k in /k out for this drug that has low albumin binding (fu of ϳ0.9) but a relatively low V suggests that there is an active uptake process. An inverse relationship between log PS and fibrosis index for ciprofloxacin (r 2 ϭ 0.68) was seen in the present study, which further suggests active transport, as we have shown that fibrosis can reduce PS for cationic drugs and taurocholate extraction in liver diseases (11, 12) . The reduced V for clindamycin attributed to a reduced cellular volume is consistent with chronic pancreatitis being associated with a reduced pancreatic volume (18) . A previous study in dogs also observed no significant change in the pancreas/plasma concentrations of clindamycin in SAP (20) .
In conclusion, the tissue kinetics of meropenem, piperacillin, ciprofloxacin, and clindamycin have been described in the perfused rat pancreas of both control animals and animals with pancreatitis. The dispositions of meropenem and piperacillin appear relatively unaffected by pancreatitis, whereas the uptake of ciprofloxacin is inhibited and there is a reduced distribution of clindamycin into pancreatic cells from animals with pancreatitis, consistent with an observed reduction in cellular volume in the pancreas of an animal with pancreatitis. Diseased animals (n ϭ 5)
